SlideShare a Scribd company logo
1 of 19
Download to read offline
The Use of Error and
Uncertainty Methods in
the Medical Laboratory
Web Based Presentation
Shrine B. Cañete
BMLS-1B
Presentation
Outline
Abstract 01
Purpose 04
Keywords & Abbreviations 02
Materials and Methods 05
Results 06
The Concepts of Bias and Imprecision 07
Performance Specifications 08
Combining Bias and Imprecision and Calculation of pTAE 09
Measurement Uncertainty 10
Discussion 11
Introduction 03
ABSTRACT
Error and uncertainty methods are complementary when evaluating
measurement data. Error methods compared with uncertainty
methods offer simpler, more intuitive and practical procedures for
calculating measurement uncertainty and conducting quality
assurance in laboratory medicine. When laboratory results are used
for supporting medical diagnoses, the total uncertainty consists only
partially of analytical variation. Biological variation, pre and
postanalytical variation all need to be included.
BMLS 1B Shrine B. Cañete
Keywords
Measurement uncertainty
Performance specification
Quality control
Total error
Abbreviations
total error (TE)
total analytical error (TAE)
measurement uncertainty (MU)
allowable total error (ATE)
Task and Finish Group on total error (TFG- TE)
Joint Committee on Guides in Metrology (JCGM)
Guide to the expression of uncertainty in
measure- ment (GUM)
International Vocabulary of Metrology (VIM)
coefficient of variation (CV)
BMLS 1B Shrine B. Cañete
To elucidate the pros and cons of error and
uncertainty methods as groundwork for future
consensus on their use in practical performance
specifications. Error and uncertainty methods are
complementary when evaluating measurement data.
of this research?
PURPOSE
Did you know the
BMLS 1B Shrine B. Cañete
The concept “total error” (TE) has different meanings to
different authors and has also changed its definition over
time. However, the widespread use of “total analytical
error” (TAE) in laboratory medicine represent a testimony to
its practical value. TAE methods are firmly rooted in
laboratory medicine, but a transition to the MU methods has
taken place in other fields of metrology. TAE methods are
commonly intertwined with quality assurance, analytical
performance specifications and Six Sigma methods , which
are only partially included in this paper.
The aim of the present paper is to fulfill the task of the TFG-
TE: to present a proposal on how to use the TE concept
and how to possibly combine measures of bias and
imprecision in performance specifications. The theoretical
and practical underpinning of TAE and uncertainty methods
are presented as groundwork for future consensus on their
use in practical performance specifications. This paper
presents the consensus as reached within the EFLM task
group but does however not represent a general EFLM
consensus.
Statements
37
were selected from the submitted
texts and presented together with
appropriate explanations
Participants
11
were subsequently invited to state
their agreements or disagreements
with the statements in writing
BMLS 1B Shrine B. Cañete
MATERIALS
AND
METHODS
The Delphi method, widely used method for achieving convergence
of opinions of experts, was used. Two Delphi iterations were used.
After an initial discussion phase of 8 months in which different views
were presented, literature was exchanged and monographs were
written
The chair of the TFG acted as moderator (WO). The TGF met to
discuss the manuscript at the Warsaw EFLM-UEMS congress, in
September 2016.
The concept of error
assumes that the difference
between the measurement
result and the “true value” or
reference quantity value can
be calculated.
In the error perspective,
measurement is seen as a process
aimed at discovering quantity
values, which have an independent
existence (the “true values”). The
better they are approximated, the
less will be the error in the
measurement result.
Concept of Error Error Perspective Performance Goal
R
e
s
u
l
t
s
BMLS 1B Shrine B. Cañete
The TAE model assumes that the
difference between a patient's
performance goal and their actual
value can be reasonably
estimated. There is no need for
separate performance goals for
bias and imprecision,
THE CONCEPTS
OF BIAS AND
IMPRECISION
Bias is the difference between the average of measurements
made on the same sample and its reference. When
uncorrected, many short-term bias components increasingly
contribute to the random error of the MU. Many effects causing
short-term bias may be seen as bias within this short time frame
but indistinguishable from random effects when variation is
observed over a longer period.
Bias is included in the conventional TAE model as a constant
without uncertainty. MU methods take this uncertainty into
account. It is composed of the uncertainty of the values of the
bias and of the reference standard. To improve the TAE
estimation, the uncertainty of the bias was suggested to be
incorporated into TAE calculation.
BMLS 1B Shrine B. Cañete
The preferred performance specification model is based on clinical
needs. However, this model can at present only be applied for only
a few measurands (e.g. HbA1c and cholesterol). The second model
is based on (components of) biological variation and can be applied
for measurands that are in steady state or can be “transformed” to a
steady-state situation in biological fluids. A third model is based on
the state of the art and can be applied in cases where models 1 and
2 cannot be used.
PERFORMANCE
SPECIFICATIONS
BMLS 1B Shrine B. Cañete
Combining bias and imprecision specifications to
set quality limits based on biological variation
was proposed by Fraser and Petersen in 1993.
BMLS 1B Shrine B. Cañete
COMBINING BIAS
AND IMPRECISION
AND CALCULATION
OF


pTAE
The performance specification was proposed for
proficiency testing but has been extensively
used to define specifications for other purposes
BMLS 1B Shrine B. Cañete
MU concept, a measurement result can
comprise two uncertainties: the
uncertainty associated with bias
correction and the uncertainty due to
imprecision. The uncertainties that act on
the measurement result are combined to
one MU statistic.
In practice, bias correction can reduce systematic
errors, and replicate measurements can diminish
the effect of random errors. However, this cannot
completely eliminate these errors. For that reason
according to the MU concept – the “true value”
cannot be exactly known. A measurement result
represents the “best estimate” of the measured
quantity.
The ultimate aim of measuring patient samples in laboratory
medicine is to improve the understanding of possible disease
conditions or to monitor treatment effects. This aim is
influenced by the uncertainties not only of the measuring
system but also by biological, pre- analytical and
postanalytical uncertainty components.
Although TAE is generally understood as total analytical error,
the types of errors included in the TE definition are varied: pre-
analytical errors, biological variation and postanalytical errors.
DISCUSSIONS
TAE methods for quantifying the
quality of measuring systems and
defining performance specifications
are widely used in laboratory
medicine.
BMLS 1B Shrine B. Cañete
C
o
n
t
i
n
u
a
t
i
o
n
o
f
D
I
S
C
U
S
S
I
O
N
BMLS 1B Shrine B. Cañete
There are several
variants in how the
calculations of TAE are
being performed and
used, with flaws in
pTAE calculations
The concept of the
“true value” has been
abandoned in
metrology. If a true
value cannot be
known, TAE cannot be
estimated. We must
use “surrogate true
values” to estimate
TAE
TE models do not
appreciate the
uncertainty of bias
estimation/correction
Among the major challenges that error methods face are the following:
1
Error methods are well understood
and widely implemented in
laboratories. Procedures for
implementing them in ISO
accreditation schemes are well
accepted by accreditation
authorities. Therefore, there are no
incentives for leaving error methods
in favor of uncertainty methods.
Methods to calculate
“permissible MU” as well as
quality assurance procedures
based on MU theory are not well
developed.
Unfamiliarity with uncertainty
calculations within most
laboratories
The level of knowledge regarding
other causes of variation than
analytical variation including
biological variation, preanalytical
and postanalytical variation
needed for the estimation of MU
is still limited.
MU methods in laboratory medicine also face several challenges:
2 3 4
Imprecision can be estimated as repeatability
imprecision at the one extreme, and reproducibility
imprecision at the other, with intermediate
imprecisions in between. Similarly, bias needs to
be estimated separately in the context of the time
frame and also the complexity of the measuring
systems, including several measuring systems in
different laboratories within a laboratory
organization. Quality assurance in laboratory
medicine needs to be more comprehensively
developed to address a situation far more
complicated than a single analyzer working in batch
mode, for which it was originally developed.
Bias and imprecision are different error types with
different causes that obviously require different
means of correction. Medical laboratories should
therefore establish and maintain routines for
estimating and minimizing them separately. Bias,
however, remains a complicating factor. MU
methods advocate correcting bias and include the
uncertainty of bias correction. Development of
analytical performance specifications for diagnostic
uncertainty has the potential of creating a paradigm
shift in laboratory medicine resulting in quality
improvements and improved use of diagnostic
methods.
Wherever the art of
Medicine is loved, there
is also a love of
Humanity.
Words to Live By
— Hippocrates
BMLS 1B Shrine B. Cañete
REFERENCE
Oosterhuis, W. P., Bayat, H., Armbruster, D.,
Coskun, A., Freeman, K. P., Kallner, A., Koch,
D., Mackenzie, F., Migliarino, G., Orth, M.,
Sandberg, S., Sylte, M. S., Westgard, S., &
Theodorsson, E. (2017). The use of error and
uncertainty methods in the medical
laboratory. Clinical Chemistry and Laboratory
Medicine (CCLM), 56(2), 209–219.
https://doi.org/10.1515/cclm-2017-0341
Shrine B. Cañete
BMLS 1B
Presented by

More Related Content

What's hot

Point of care testing
Point of care testingPoint of care testing
Point of care testingkamalmodi481
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPAFP
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care TestingLAB IDEA
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperRandox
 
Quality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesQuality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesjdyjdo
 
Point of care testing ( POCT)
Point of care testing ( POCT)Point of care testing ( POCT)
Point of care testing ( POCT)binaya tamang
 
Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...drucsamal
 
Statistical Issues In Medical Device Trials
Statistical Issues In Medical Device TrialsStatistical Issues In Medical Device Trials
Statistical Issues In Medical Device TrialsJacobe2008
 
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelInnovation Agency
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines ResumeCorey Raines
 
Poct diabetes mellitus
Poct diabetes mellitusPoct diabetes mellitus
Poct diabetes mellitusjdyjdo
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Lyssa Friedman
 
Immqas enhancing immunodiagnostic investigations
Immqas enhancing immunodiagnostic investigationsImmqas enhancing immunodiagnostic investigations
Immqas enhancing immunodiagnostic investigationszanet1
 
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Yasser Sami Abdel Dayem Amer
 
How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?Canadian Cancer Survivor Network
 
Emerging diagnostic technologies proving the clinical application through g...
Emerging diagnostic technologies   proving the clinical application through g...Emerging diagnostic technologies   proving the clinical application through g...
Emerging diagnostic technologies proving the clinical application through g...Lyssa Friedman
 

What's hot (20)

Point of care testing
Point of care testingPoint of care testing
Point of care testing
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
 
Point Of Care Testing
Point Of Care TestingPoint Of Care Testing
Point Of Care Testing
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
 
Quality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesQuality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratories
 
Point of care testing ( POCT)
Point of care testing ( POCT)Point of care testing ( POCT)
Point of care testing ( POCT)
 
Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...Thermo fischer scientific point of care testing for advanced patient stratifi...
Thermo fischer scientific point of care testing for advanced patient stratifi...
 
Statistical Issues In Medical Device Trials
Statistical Issues In Medical Device TrialsStatistical Issues In Medical Device Trials
Statistical Issues In Medical Device Trials
 
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines Resume
 
40718
4071840718
40718
 
Resume_BB
Resume_BBResume_BB
Resume_BB
 
Poct diabetes mellitus
Poct diabetes mellitusPoct diabetes mellitus
Poct diabetes mellitus
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
 
Immqas enhancing immunodiagnostic investigations
Immqas enhancing immunodiagnostic investigationsImmqas enhancing immunodiagnostic investigations
Immqas enhancing immunodiagnostic investigations
 
SMART Tox Flyer copy
SMART Tox Flyer copySMART Tox Flyer copy
SMART Tox Flyer copy
 
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
 
How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?How Timely is Canada’s Medication Review and Approval Process?
How Timely is Canada’s Medication Review and Approval Process?
 
Emerging diagnostic technologies proving the clinical application through g...
Emerging diagnostic technologies   proving the clinical application through g...Emerging diagnostic technologies   proving the clinical application through g...
Emerging diagnostic technologies proving the clinical application through g...
 
Clinical Trial Primer
Clinical Trial PrimerClinical Trial Primer
Clinical Trial Primer
 

Similar to The Use Of Error and Uncertainty Methods in the Medical Laboratory

Physician performance improvement part one
Physician performance improvement part onePhysician performance improvement part one
Physician performance improvement part oneRobert Sutter
 
Ich guidelines e9 to e12
Ich guidelines e9 to e12Ich guidelines e9 to e12
Ich guidelines e9 to e12Khushboo Bhatia
 
qc histo ss final - Copy.pptx
qc histo ss final - Copy.pptxqc histo ss final - Copy.pptx
qc histo ss final - Copy.pptxRavi Kothari
 
Cadth 2015 c2 tt eincea_cadth_042015
Cadth 2015 c2 tt eincea_cadth_042015Cadth 2015 c2 tt eincea_cadth_042015
Cadth 2015 c2 tt eincea_cadth_042015CADTH Symposium
 
· Reflect on the four peer-reviewed articles you critically apprai.docx
· Reflect on the four peer-reviewed articles you critically apprai.docx· Reflect on the four peer-reviewed articles you critically apprai.docx
· Reflect on the four peer-reviewed articles you critically apprai.docxVannaJoy20
 
A gentle introduction to meta-analysis
A gentle introduction to meta-analysisA gentle introduction to meta-analysis
A gentle introduction to meta-analysisAngelo Tinazzi
 
Esperimento di report cqi cqa
Esperimento di report cqi cqaEsperimento di report cqi cqa
Esperimento di report cqi cqaMaurizio Piu
 
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docxodiliagilby
 
International Journal of Technology Assessment in Health Care,
International Journal of Technology Assessment in Health Care,International Journal of Technology Assessment in Health Care,
International Journal of Technology Assessment in Health Care,TatianaMajor22
 
Bioanalytical Method Validation Fda Perspective
Bioanalytical Method Validation   Fda PerspectiveBioanalytical Method Validation   Fda Perspective
Bioanalytical Method Validation Fda PerspectiveDebanjan (Deb) Das
 
LC-MS methods for regulated bioequivalence
LC-MS methods for regulated bioequivalenceLC-MS methods for regulated bioequivalence
LC-MS methods for regulated bioequivalenceBhaswat Chakraborty
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Luis Bravo(Marketing)
 
An illustrated guide to the methods of meta analysi
An illustrated guide to the methods of meta analysiAn illustrated guide to the methods of meta analysi
An illustrated guide to the methods of meta analysirsd kol abundjani
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxclarebernice
 
Automated Extraction Of Reported Statistical Analyses Towards A Logical Repr...
Automated Extraction Of Reported Statistical Analyses  Towards A Logical Repr...Automated Extraction Of Reported Statistical Analyses  Towards A Logical Repr...
Automated Extraction Of Reported Statistical Analyses Towards A Logical Repr...Nat Rice
 
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docxoswald1horne84988
 
Assignment 4 Training StrategyMiatta TeasleyCa.docx
Assignment 4 Training StrategyMiatta TeasleyCa.docxAssignment 4 Training StrategyMiatta TeasleyCa.docx
Assignment 4 Training StrategyMiatta TeasleyCa.docxjesuslightbody
 
Clinical audit by Dr A. K. Khandelwal
Clinical audit  by Dr A. K. KhandelwalClinical audit  by Dr A. K. Khandelwal
Clinical audit by Dr A. K. KhandelwalDr.Ashok Khandelwal
 

Similar to The Use Of Error and Uncertainty Methods in the Medical Laboratory (20)

Interpretative Lab reports
Interpretative Lab reportsInterpretative Lab reports
Interpretative Lab reports
 
Physician performance improvement part one
Physician performance improvement part onePhysician performance improvement part one
Physician performance improvement part one
 
Ich guidelines e9 to e12
Ich guidelines e9 to e12Ich guidelines e9 to e12
Ich guidelines e9 to e12
 
qc histo ss final - Copy.pptx
qc histo ss final - Copy.pptxqc histo ss final - Copy.pptx
qc histo ss final - Copy.pptx
 
Cadth 2015 c2 tt eincea_cadth_042015
Cadth 2015 c2 tt eincea_cadth_042015Cadth 2015 c2 tt eincea_cadth_042015
Cadth 2015 c2 tt eincea_cadth_042015
 
· Reflect on the four peer-reviewed articles you critically apprai.docx
· Reflect on the four peer-reviewed articles you critically apprai.docx· Reflect on the four peer-reviewed articles you critically apprai.docx
· Reflect on the four peer-reviewed articles you critically apprai.docx
 
A gentle introduction to meta-analysis
A gentle introduction to meta-analysisA gentle introduction to meta-analysis
A gentle introduction to meta-analysis
 
Esperimento di report cqi cqa
Esperimento di report cqi cqaEsperimento di report cqi cqa
Esperimento di report cqi cqa
 
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx
[Ann Emerg Med. 2009;53685-687.]Systematic Review SourceThis .docx
 
International Journal of Technology Assessment in Health Care,
International Journal of Technology Assessment in Health Care,International Journal of Technology Assessment in Health Care,
International Journal of Technology Assessment in Health Care,
 
Bioanalytical Method Validation Fda Perspective
Bioanalytical Method Validation   Fda PerspectiveBioanalytical Method Validation   Fda Perspective
Bioanalytical Method Validation Fda Perspective
 
LC-MS methods for regulated bioequivalence
LC-MS methods for regulated bioequivalenceLC-MS methods for regulated bioequivalence
LC-MS methods for regulated bioequivalence
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)
 
An illustrated guide to the methods of meta analysi
An illustrated guide to the methods of meta analysiAn illustrated guide to the methods of meta analysi
An illustrated guide to the methods of meta analysi
 
my poster
my postermy poster
my poster
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
 
Automated Extraction Of Reported Statistical Analyses Towards A Logical Repr...
Automated Extraction Of Reported Statistical Analyses  Towards A Logical Repr...Automated Extraction Of Reported Statistical Analyses  Towards A Logical Repr...
Automated Extraction Of Reported Statistical Analyses Towards A Logical Repr...
 
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
· Psychiatric Mental Health Nursing. Scope and Standards of Practi.docx
 
Assignment 4 Training StrategyMiatta TeasleyCa.docx
Assignment 4 Training StrategyMiatta TeasleyCa.docxAssignment 4 Training StrategyMiatta TeasleyCa.docx
Assignment 4 Training StrategyMiatta TeasleyCa.docx
 
Clinical audit by Dr A. K. Khandelwal
Clinical audit  by Dr A. K. KhandelwalClinical audit  by Dr A. K. Khandelwal
Clinical audit by Dr A. K. Khandelwal
 

Recently uploaded

Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...Lokesh Kothari
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000Sapana Sha
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPirithiRaju
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksSérgio Sacani
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptxRajatChauhan518211
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)Areesha Ahmad
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfSumit Kumar yadav
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)Areesha Ahmad
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencySheetal Arora
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and ClassificationsAreesha Ahmad
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
 

Recently uploaded (20)

Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...
GUIDELINES ON SIMILAR BIOLOGICS Regulatory Requirements for Marketing Authori...
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disks
 
Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptx
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdf
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls AgencyHire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
Hire 💕 9907093804 Hooghly Call Girls Service Call Girls Agency
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
 

The Use Of Error and Uncertainty Methods in the Medical Laboratory

  • 1. The Use of Error and Uncertainty Methods in the Medical Laboratory Web Based Presentation Shrine B. Cañete BMLS-1B
  • 2. Presentation Outline Abstract 01 Purpose 04 Keywords & Abbreviations 02 Materials and Methods 05 Results 06 The Concepts of Bias and Imprecision 07 Performance Specifications 08 Combining Bias and Imprecision and Calculation of pTAE 09 Measurement Uncertainty 10 Discussion 11 Introduction 03
  • 3. ABSTRACT Error and uncertainty methods are complementary when evaluating measurement data. Error methods compared with uncertainty methods offer simpler, more intuitive and practical procedures for calculating measurement uncertainty and conducting quality assurance in laboratory medicine. When laboratory results are used for supporting medical diagnoses, the total uncertainty consists only partially of analytical variation. Biological variation, pre and postanalytical variation all need to be included. BMLS 1B Shrine B. Cañete
  • 4. Keywords Measurement uncertainty Performance specification Quality control Total error Abbreviations total error (TE) total analytical error (TAE) measurement uncertainty (MU) allowable total error (ATE) Task and Finish Group on total error (TFG- TE) Joint Committee on Guides in Metrology (JCGM) Guide to the expression of uncertainty in measure- ment (GUM) International Vocabulary of Metrology (VIM) coefficient of variation (CV) BMLS 1B Shrine B. Cañete
  • 5. To elucidate the pros and cons of error and uncertainty methods as groundwork for future consensus on their use in practical performance specifications. Error and uncertainty methods are complementary when evaluating measurement data. of this research? PURPOSE Did you know the BMLS 1B Shrine B. Cañete
  • 6. The concept “total error” (TE) has different meanings to different authors and has also changed its definition over time. However, the widespread use of “total analytical error” (TAE) in laboratory medicine represent a testimony to its practical value. TAE methods are firmly rooted in laboratory medicine, but a transition to the MU methods has taken place in other fields of metrology. TAE methods are commonly intertwined with quality assurance, analytical performance specifications and Six Sigma methods , which are only partially included in this paper. The aim of the present paper is to fulfill the task of the TFG- TE: to present a proposal on how to use the TE concept and how to possibly combine measures of bias and imprecision in performance specifications. The theoretical and practical underpinning of TAE and uncertainty methods are presented as groundwork for future consensus on their use in practical performance specifications. This paper presents the consensus as reached within the EFLM task group but does however not represent a general EFLM consensus.
  • 7. Statements 37 were selected from the submitted texts and presented together with appropriate explanations Participants 11 were subsequently invited to state their agreements or disagreements with the statements in writing BMLS 1B Shrine B. Cañete MATERIALS AND METHODS The Delphi method, widely used method for achieving convergence of opinions of experts, was used. Two Delphi iterations were used. After an initial discussion phase of 8 months in which different views were presented, literature was exchanged and monographs were written The chair of the TFG acted as moderator (WO). The TGF met to discuss the manuscript at the Warsaw EFLM-UEMS congress, in September 2016.
  • 8. The concept of error assumes that the difference between the measurement result and the “true value” or reference quantity value can be calculated. In the error perspective, measurement is seen as a process aimed at discovering quantity values, which have an independent existence (the “true values”). The better they are approximated, the less will be the error in the measurement result. Concept of Error Error Perspective Performance Goal R e s u l t s BMLS 1B Shrine B. Cañete The TAE model assumes that the difference between a patient's performance goal and their actual value can be reasonably estimated. There is no need for separate performance goals for bias and imprecision,
  • 9. THE CONCEPTS OF BIAS AND IMPRECISION Bias is the difference between the average of measurements made on the same sample and its reference. When uncorrected, many short-term bias components increasingly contribute to the random error of the MU. Many effects causing short-term bias may be seen as bias within this short time frame but indistinguishable from random effects when variation is observed over a longer period. Bias is included in the conventional TAE model as a constant without uncertainty. MU methods take this uncertainty into account. It is composed of the uncertainty of the values of the bias and of the reference standard. To improve the TAE estimation, the uncertainty of the bias was suggested to be incorporated into TAE calculation. BMLS 1B Shrine B. Cañete
  • 10. The preferred performance specification model is based on clinical needs. However, this model can at present only be applied for only a few measurands (e.g. HbA1c and cholesterol). The second model is based on (components of) biological variation and can be applied for measurands that are in steady state or can be “transformed” to a steady-state situation in biological fluids. A third model is based on the state of the art and can be applied in cases where models 1 and 2 cannot be used. PERFORMANCE SPECIFICATIONS BMLS 1B Shrine B. Cañete
  • 11. Combining bias and imprecision specifications to set quality limits based on biological variation was proposed by Fraser and Petersen in 1993. BMLS 1B Shrine B. Cañete COMBINING BIAS AND IMPRECISION AND CALCULATION OF pTAE The performance specification was proposed for proficiency testing but has been extensively used to define specifications for other purposes
  • 12. BMLS 1B Shrine B. Cañete MU concept, a measurement result can comprise two uncertainties: the uncertainty associated with bias correction and the uncertainty due to imprecision. The uncertainties that act on the measurement result are combined to one MU statistic. In practice, bias correction can reduce systematic errors, and replicate measurements can diminish the effect of random errors. However, this cannot completely eliminate these errors. For that reason according to the MU concept – the “true value” cannot be exactly known. A measurement result represents the “best estimate” of the measured quantity.
  • 13. The ultimate aim of measuring patient samples in laboratory medicine is to improve the understanding of possible disease conditions or to monitor treatment effects. This aim is influenced by the uncertainties not only of the measuring system but also by biological, pre- analytical and postanalytical uncertainty components. Although TAE is generally understood as total analytical error, the types of errors included in the TE definition are varied: pre- analytical errors, biological variation and postanalytical errors. DISCUSSIONS TAE methods for quantifying the quality of measuring systems and defining performance specifications are widely used in laboratory medicine. BMLS 1B Shrine B. Cañete
  • 14. C o n t i n u a t i o n o f D I S C U S S I O N BMLS 1B Shrine B. Cañete There are several variants in how the calculations of TAE are being performed and used, with flaws in pTAE calculations The concept of the “true value” has been abandoned in metrology. If a true value cannot be known, TAE cannot be estimated. We must use “surrogate true values” to estimate TAE TE models do not appreciate the uncertainty of bias estimation/correction Among the major challenges that error methods face are the following:
  • 15. 1 Error methods are well understood and widely implemented in laboratories. Procedures for implementing them in ISO accreditation schemes are well accepted by accreditation authorities. Therefore, there are no incentives for leaving error methods in favor of uncertainty methods. Methods to calculate “permissible MU” as well as quality assurance procedures based on MU theory are not well developed. Unfamiliarity with uncertainty calculations within most laboratories The level of knowledge regarding other causes of variation than analytical variation including biological variation, preanalytical and postanalytical variation needed for the estimation of MU is still limited. MU methods in laboratory medicine also face several challenges: 2 3 4
  • 16. Imprecision can be estimated as repeatability imprecision at the one extreme, and reproducibility imprecision at the other, with intermediate imprecisions in between. Similarly, bias needs to be estimated separately in the context of the time frame and also the complexity of the measuring systems, including several measuring systems in different laboratories within a laboratory organization. Quality assurance in laboratory medicine needs to be more comprehensively developed to address a situation far more complicated than a single analyzer working in batch mode, for which it was originally developed. Bias and imprecision are different error types with different causes that obviously require different means of correction. Medical laboratories should therefore establish and maintain routines for estimating and minimizing them separately. Bias, however, remains a complicating factor. MU methods advocate correcting bias and include the uncertainty of bias correction. Development of analytical performance specifications for diagnostic uncertainty has the potential of creating a paradigm shift in laboratory medicine resulting in quality improvements and improved use of diagnostic methods.
  • 17. Wherever the art of Medicine is loved, there is also a love of Humanity. Words to Live By — Hippocrates BMLS 1B Shrine B. Cañete
  • 18. REFERENCE Oosterhuis, W. P., Bayat, H., Armbruster, D., Coskun, A., Freeman, K. P., Kallner, A., Koch, D., Mackenzie, F., Migliarino, G., Orth, M., Sandberg, S., Sylte, M. S., Westgard, S., & Theodorsson, E. (2017). The use of error and uncertainty methods in the medical laboratory. Clinical Chemistry and Laboratory Medicine (CCLM), 56(2), 209–219. https://doi.org/10.1515/cclm-2017-0341
  • 19. Shrine B. Cañete BMLS 1B Presented by